
AstraZeneca temporarily paused its COVID-19 vaccine trial due to an unexplained illness in a study participant, who is said to recover soon.
Further, AstraZeneca, in a statement, said that in such large trials, illnesses are bound to happen by chance, and must be independently reviewed to check this carefully. A spokesperson for AstraZeneca said that their trials are of the highest standards and that the safety and health of the patient would be of utmost concern during the trial phases. They also explained it was a 'routine action' and that it is speeding up the investigation to minimize any potential impact on the trial's timeline.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.
Copied!